HOME >> MEDICINE >> NEWS
Gene mutations predict which lung cancers will respond to Iressa

Researchers from the Massachusetts General Hospital (MGH) Cancer Center have discovered a molecular marker that identifies lung cancer patients whose tumors will respond to treatment with the drug Iressa (gefitinib). Their findings, which will be published in the May 20 New England Journal of Medicine, are being released online today to coincide with the online release by Science of related research from Dana-Farber Cancer Institute.

"This discovery will help us significantly improve the treatment of many lung cancer patients and is also an important next step in the molecular targeting of cancer drugs," says Daniel Haber, MD, PhD, director of the MGH Cancer Center and senior author of the NEJM paper. "We're hopeful that what we have learned will eventually lead to more new drugs that will target tumor-specific mutations without affecting normal tissues."

Iressa was approved a year ago for the treatment of advanced non-small-cell lung cancer (NSCLC), a tumor that is particularly difficult to treat and is the leading cause of cancer deaths in the U.S. In a major clinical trial Iressa caused tumors to shrink significantly in only 13.6 percent of patients, but some of those responses were rapid and dramatic. As a result, the FDA approved the drug because there are no other treatment options for NSCLC patients for whom standard chemotherapy has failed.

Iressa acts by disabling the epidermal growth factor receptor (EGFR) on the surface of lung cancer cells, halting a sequence of signals that can lead to the uncontrolled growth characterizing a malignant tumor. In their search for an answer to why the drug worked so well for some NSCLC patients but was of no assistance to others, the MGH team screened tumor samples from MGH patients who participated in the Iressa clinical trial to search for mutations in the EGFR gene.

Initial analysis found mutations affecting the same area (the ATP cleft of the kinase domain) of the receptor prot
'"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
29-Apr-2004


Page: 1 2 3

Related medicine news :

1. Non-invasive and invasive breast cancers share the same genetic mutations
2. Both inherited traits and tumor mutations affect response to treatment of leukemia
3. Small increases or blips in HIV levels do not signal mutations leading to drug-resistant HIV
4. Gene mutations responsible for childhood cataracts discovered
5. Breast cancer patients with BRCA1 or 2 mutations twice as likely to have double mastectomy
6. Breast cancer patients with BRCA 1/2 mutations twice as likely to choose double mastectomy
7. Mayo Clinic researchers discover gene mutations that ignore stress, lead to heart failure
8. In 15 seconds, new test will ID presence of 25 most common mutations of cystic fibrosis
9. Northwestern on trail of gene mutations that trigger sex reversal
10. Gene mutations found that lead to prostate cancer in mice new mouse model developed to study the disease
11. New evaluation tool reliably predicts recovery from coma

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/28/2020)... ... 28, 2020 , ... Integrated Viral Protection (IVP Air) today announced ... deploy its breakthrough Mobile Biodefense Indoor Air Protection System that is the first system ... to fully reopen equipped with the filtration system on September 8th. , The ...
(Date:8/28/2020)... LOS ANGELES (PRWEB) , ... August 28, 2020 ... ... reports on international observations that strongly suggest that obese individuals are at an ... obese people are any more likely to catch COVID-19; however, because the same ...
(Date:8/27/2020)... ... August 27, 2020 , ... The team ... leading aesthetic and wellness retreat. The practice is centered on results and providing ... Vegas. , Designed to be a sanctuary for total body renewal and ...
(Date:8/26/2020)... ... August 26, 2020 , ... Smile Brands Inc. CEO, Steven ... Forum, leading a session entitled, “A CEO Guide for Delivering and Measuring Inclusion ... to bring together the world’s leading diversity and inclusion executives, HR consultants, and ...
(Date:8/26/2020)... ... August 26, 2020 , ... In “ U.S. Health Insurance ... from their biennial survey of adults aged 19-64 about their healthcare coverage. The survey ... the pandemic outbreak, and concluding on June 4, more than two months into the ...
Breaking Medicine News(10 mins):
(Date:8/26/2020)... ... August 26, 2020 , ... ScripHessco ... Sports Injuries. The infographic breaks down ways that chiropractors can help heal sports ... According to ScripHessco “Athletes have an unusual amount of pressure and stress on ...
(Date:8/26/2020)... (PRWEB) , ... August 26, ... ... member of Eurofins BioPharma Services, Laboratory Testing division, expands its technology footprint ... suite of Flow Cytometry platforms available. With industry-leading biomarker solutions, complemented with ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... announced that it has entered into definitive agreement to acquire ProCE, a ... on pharmacists and pharmacy technicians. , CEA represents a growing alliance ...
Breaking Medicine Technology:
Cached News: